Skip to main content

HOSPITAL

19/05/2022

A work led by Dr. Raul Herance wins an award at the European Molecular Imaging Meeting

Premi EMIM Dr. Raul Herance

19/05/2022

The head of the Medical Molecular Imaging group at VHIR received the recognition for the best poster presentation for a study on myocardial insulin resistance and cardiovascular risk.

Dr. J Raul Herance, head of the Medical Molecular Imaging group at Vall d'Hebron Research Institute (VHIR) has received the award for best poster presentation at the European Molecular Imaging Meeting (EMIM 2022) in the Metabolic Imaging category, for the paper "Phenotyping type 2 diabetes in terms of myocardial insulin resistance and its potential cardiovascular consequences: a new strategy based on 18F-FDG PET/CT" published in the Journal of Personalized Medicine.

The study, led by the Medical Molecular Imaging and Diabetes and Metabolism groups at VHIR, identified that 60% of patients with controlled type 2 diabetes have myocardial insulin resistance and as a consequence have structural changes in the myocardium and more calcifications in the coronary arteries, thus more cardiovascular risk.

Researchers have developed an innovative methodology that allows precise determination of insulin resistance in myocardium in vivo through PET/CT, which has made it possible to phenotype patients with type 2 diabetes into two groups, while determining structural alterations in the heart and calcifications in the coronary arteries. Calcifications in the coronary arteries are one of the main risk factors for cardiovascular complications. For this reason, it has been possible to relate that patients with myocardial insulin resistance would be more likely to suffer this type of events.

European Molecular Imaging Congress

The European Molecular Imaging Meeting (EMIM) is the annual meeting of the European Molecular Imaging Society. More than 800 international professionals dedicated to medical imaging in biomedicine attended the 17th edition, held last March in Thessaloniki (Greece). In total, 218 posters were presented, among which 5 prizes were awarded.

Related news

En les consultes de la Unitat de Tractament Integral de l’Obesitat de Vall d’Hebron els avenços de la recerca estan molt presents, ja sigui en forma d’assaig clínic o mitjançant la utilització d’unes ulleres de realitat virtual.

Onze investigadors i investigadores de Vall d’Hebron faran xerrades i tallers amb l’objectiu d’apropar la ciència a tothom.

The Ministry of Science and Innovation granted more than €1.4 million to the project "Early molecular nanoDIAGnostics of Brain tumours using ImmunePET (DIAGBI)" with the participation of Vall d’Hebron through the Molecular Medicine Imaging Group.

Related professionals

Andreea Ciudin Mihai

Andreea Ciudin Mihai

Predoctoral researcher
Diabetes and Metabolism
Read more
Alberto Roque Pérez

Alberto Roque Pérez

Molecular Medical Imaging
Read more
Marc Rivas Agudo

Marc Rivas Agudo

Research technician
Diabetes and Metabolism
Read more
Manuel Escobar Amores

Manuel Escobar Amores

Administration and Management
Molecular Medical Imaging
Read more

Subscriu-te als nostres butlletíns i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.